Pharmafile - Research and Development News
New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the NHS to help diagnose pre...
A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers found...
All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity and lower the risk of severe illness.
According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under a pessimistic scenario, will be faced...
TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an...
Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in vivo base editing...
The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with HER2-...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical...
Leading sexual health organisations have warned that monkeypox could become endemic in the UK if the government does not take further action.
Steve Barclay former chief of staff at Number 10 Downing Street, has been appointed new Health Secretary, following the resignation of former Health...